Respiratory Syncytial Virus (RSV) Vaccine
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 7 of these applications claim priority to application PCT/EP2014/002301, filed Aug 21, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,688,729 | Respiratory Syncytial Virus (RSV) Vaccine In force · High confidence UsedRemaining | Curevac SE | In force | High confidence | ||
| US 10,150,797 | Respiratory Syncytial Virus (RSV) Vaccine In force · High confidence | Curevac SE | In force | High confidence | ||
| US 11,034,729 | Respiratory Syncytial Virus (RSV) Vaccine In force · High confidence | Curevac SE | In force | High confidence | ||
| US 11,739,125 | Respiratory Syncytial Virus (RSV) Vaccine In force · Medium confidence | Curevac SE | In force | Medium confidence | ||
| US 11,965,000 | Respiratory Syncytial Virus (RSV) Vaccine In force · Medium confidence | CureVac SE | In force | Medium confidence | ||
| US 12,139,513 | Respiratory Syncytial Virus (RSV) Vaccine In force · Medium confidence | CureVac SE | In force | Medium confidence | ||
| US 12,240,873 | Respiratory Syncytial Virus (RSV) Vaccine In force · Medium confidence | CureVac SE | In force | Medium confidence | ||
| Application 18/348,042 | Respiratory Syncytial Virus (RSV) Vaccine Abandoned Abandoned Oct 26, 2023 | CureVac SE | Abandoned | Abandoned Oct 26, 2023 | ||
| Application 19/004,853 | Respiratory Syncytial Virus (RSV) Vaccine Pending Not granted | CureVac SE | Pending | Not granted |
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
7 of these are in force and held by CureVac AG.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.